Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence
Jiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang · 2026
Read Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence by Jiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13359912.txt.
Description
Jiaojiao Fan and co-authors build a cell model of chemotherapy heart damage in a 2026 study. Doxorubicin cures many cancers but can age heart cells early, a process called senescence that limits the drug's use. The team exposed rat heart muscle cells, H9C2, to a low dose of the drug and produced a stable senescence model with clear aging markers and faulty mitochondria.
They then tested SS-31, a compound that targets mitochondria. It reversed key aging signs and lowered cell stress in the model. The setup gives drug hunters a reliable screen for heart-protective candidates, and SS-31 itself emerges as a promising shield.
Catalog record
| CREATOR | Jiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30231 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |